ATE315382T1 - Pharmazeutische zusammensetzungen zur oralen verabreichung, die einen magensaftresistenten überzug auf der basis von acrylatpolymeren enthalten - Google Patents

Pharmazeutische zusammensetzungen zur oralen verabreichung, die einen magensaftresistenten überzug auf der basis von acrylatpolymeren enthalten

Info

Publication number: ATE315382T1
Authority: AT; Austria
Prior art keywords: pharmaceutical compositions; oral administration; entericial; resistant coating; acrylate polymers
Prior art date: 1998-11-13

Application number

AT99122470T

Other languages

English (en)

Inventor

Roberto Cacciaglia

Anna Maria Cantarelli

Sandra Tavazzi

Loredana Ugolotti

Original Assignee

Ct Lab Farm Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-13

Filing date

1999-11-11

Publication date

2006-02-15

1999-11-11 Application filed by Ct Lab Farm Srl filed Critical Ct Lab Farm Srl

2006-02-15 Application granted granted Critical

2006-02-15 Publication of ATE315382T1 publication Critical patent/ATE315382T1/de

Links

239000011248 coating agent Substances 0.000 title abstract 2
238000000576 coating method Methods 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
229920000058 polyacrylate Polymers 0.000 title 1
239000004480 active ingredient Substances 0.000 abstract 3
BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 abstract 2
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 abstract 1
VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 abstract 1
230000002757 inflammatory effect Effects 0.000 abstract 1
208000028774 intestinal disease Diseases 0.000 abstract 1
210000000936 intestine Anatomy 0.000 abstract 1
230000000622 irritating effect Effects 0.000 abstract 1
KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 abstract 1
229960004963 mesalazine Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920001897 terpolymer Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT99122470T 1998-11-13 1999-11-11 Pharmazeutische zusammensetzungen zur oralen verabreichung, die einen magensaftresistenten überzug auf der basis von acrylatpolymeren enthalten ATE315382T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT1998MI002467A IT1303753B1 (it)	1998-11-13	1998-11-13	Composizioni farmaceutiche somministrabili per via orale contenentiun rivestimento gastroresistente a base di polimeri acrilici.

Publications (1)

Publication Number	Publication Date
ATE315382T1 true ATE315382T1 (de)	2006-02-15

Family

ID=11381056

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99122470T ATE315382T1 (de)	1998-11-13	1999-11-11	Pharmazeutische zusammensetzungen zur oralen verabreichung, die einen magensaftresistenten überzug auf der basis von acrylatpolymeren enthalten

Country Status (4)

Country	Link
EP (1)	EP1004297B1 (de)
AT (1)	ATE315382T1 (de)
DE (1)	DE69929387D1 (de)
IT (1)	IT1303753B1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10013030A1 (de) *	2000-03-17	2001-09-20	Roehm Gmbh	Verwendung eines Copolymers zur Herstellung einer Arzneiform zur Therapie von Colitis ulcerosa und verwendungsgemäße Arzneiform
RU2286156C2 (ru) *	2001-10-15	2006-10-27	Ферринг Бв	Способ приготовления фармацевтической композиции, включающей в себя 5-аминосалициловую кислоту, для применения в лечении неспецифического язвенного колита и болезни крона
CN100506234C (zh) *	2001-10-15	2009-07-01	凡林有限公司	用于治疗溃疡性结肠炎和克罗恩病的含有5-氨基水杨酸的药物组合物的制备方法
US8282955B2 (en) *	2001-10-15	2012-10-09	Ferring B.V.	Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
BG65471B1 (bg) *	2002-04-02	2008-09-30	"Софарма" Ад	Лекарствена форма на мезалазин и метод за нейнотополучаване
WO2004093883A2 (en)	2003-04-23	2004-11-04	Ferring B.V.	Sachet for a pharmaceutical composition
ITMI20032087A1 (it) *	2003-10-27	2005-04-28	Pharmafilm S R L	Film autosupportanti per uso farmaceutico ed alimentare.
ITUB20160203A1 (it) *	2016-01-19	2017-07-19	Valpharma Int Spa	Formulazioni in compresse a rilascio modificato contenenti Mesalazina ad alto dosaggio, processo per la loro preparazione e loro uso.
ITUA20162293A1 (it) *	2016-04-05	2017-10-05	Sofar Spa	Processo per formulazioni solide di mesalazina
IT201800005908A1 (it) *	2018-05-31	2019-12-01		Compressa gastroresistente rivestita con film per il rilascio protratto di acido butirrico

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA825384B (en) *	1981-07-31	1983-05-25	Tillott J B Ltd	Orally administrable pharmaceutical compositions
DE9414066U1 (de) *	1994-08-31	1994-11-03	Röhm GmbH & Co. KG, 64293 Darmstadt	Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform

1998
- 1998-11-13 IT IT1998MI002467A patent/IT1303753B1/it active
1999
- 1999-11-11 EP EP99122470A patent/EP1004297B1/de not_active Expired - Lifetime
- 1999-11-11 AT AT99122470T patent/ATE315382T1/de not_active IP Right Cessation
- 1999-11-11 DE DE69929387T patent/DE69929387D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
IT1303753B1 (it)	2001-02-23
ITMI982467A1 (it)	2000-05-13
EP1004297B1 (de)	2006-01-11
EP1004297A1 (de)	2000-05-31
DE69929387D1 (de)	2006-04-06

Similar Documents

Publication	Publication Date	Title
AU563725B2 (en)	1987-07-23	Oral controlled release multiple unit formulation
SE9301489D0 (sv)	1993-04-30	Veterinary composition
NZ503946A (en)	2003-02-28	Oral dosage form in an oval or caplet shape for administration of bisphosphonates and other known medicaments
MX9804008A (es)	1998-09-30	Formulaciones farmaceuticas.
ATE129893T1 (de)	1995-11-15	Orale dosierungsform mit verzögerter wirkstoffabgabe für die behandlung von intestinalen krankheiten.
DE69331906D1 (de)	2002-06-13	Granulierte pharmazeutische zusammensetzung
IL111647A (en)	1999-12-22	Pharmaceutical compositions comprising microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles and their preparation
NO975872D0 (no)	1997-12-12	Formuleringer for kontrollert frigjöring av lite opplöselige medikamenter
ATE260648T1 (de)	2004-03-15	Überzugs- und bindemittel für arzneiformen sowie damit hergestellte arzneiform
UA88056C2 (uk)	2009-09-10	Дозована форма оксикодону, що вводиться один раз на день
EP0136103B1 (de)	1990-10-31	Amosulalolhydrochlorid-Formulierungen mit lang anhaltender Wirkung
DE69929387D1 (de)	2006-04-06	Pharmazeutische Zusammensetzungen zur oralen Verabreichung, die einen magensaftresistenten Überzug auf der Basis von Acrylatpolymeren enthalten
CY1108863T1 (el)	2014-07-02	Φαρμακευτικο σκευασμα εκτεταμενης απελευθερωσης ανεξαρτητης απο το ρη
CA2219777A1 (en)	1996-11-14	Nanoparticles for oral administration of pharmaceutical agents of low solubility
HUP0001084A2 (hu)	2000-11-28	5-ASA-t tartalmazó, módosított hatóanyag-felszabadulást biztosító orális gyógyászati készítmény bélbetegségek kezelésére
CA2383212A1 (en)	2001-03-08	Controlled release oral dosage suitable for oral administration
DZ2316A1 (fr)	2002-12-28	Micro sphères pharmaceutiques d'acide valproique pour administration orale.
DE60006362D1 (de)	2003-12-11	Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
CA2299423A1 (en)	2000-09-02	Taste-masked pharmaceutical composition
GB9924636D0 (en)	1999-12-22	Laxative preparation
BE880648A (fr)	1980-06-17	Nouvelles formes galeniques d'administration de medicaments par voie orale, aliberation programmee et leurs procedes de preparation
CA2161683A1 (en)	1994-11-10	Veterinary composition containing a proton pump inhibitor
CO4910116A1 (es)	2000-04-24	Formulacion de liberacion controlada para farmacos basicos escasamente solubles
TH27939B (th)	1998-02-16	สูตรส่วนผสมทางเภสัช
IT1254688B (it)	1995-09-28	Composizioni farmaceutiche somministrabili per via orale a rilascio mirato contenenti acido ursodesossicolico ed acido chenodesossicolico.

Legal Events

Date	Code	Title	Description
2006-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties